A new GAO report finds the FDA incapable of reviewing all drug advertising -- including the identification of off-label promotions -- due to the quantity of submissions and the variety of materials.

Nielsen and Wolters Kluwer Health have formed an alliance to create HealthScape, offering marketers access to anonymous prescription-related transaction data as well as consumer purchasing trends.

Rob Rogers and Louisa Holland have been promoted to co-CEO of Sudler and Hennessey's operations in the Americas.

GlaxoSmithKline is seeing a "leveling off of the impact" of Chantix on sales of its behind-the-counter nicotine replacement therapies (NRT) amid concerns about the safety of the smoking cessation drug.

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.

The head of the House of Representatives Energy and Commerce subcommittee is calling for tougher restrictions on DTC television advertising for prescription drugs.

Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.

Once a product has been positioned and its brand story told, it's time to develop a creative concept. Cathy Su and Noah Pines look at marketing research techniques that help evolve visual executions, resulting in truly effective ads

There is no point in running a great journal ad if no one notices it. But how do you truly determine if the signal is cutting through the noise? Stephen Hellebusch tests the theory of signal detectability on a group of primary care physicians

Pfizer pulled Lipitor ads featuring Dr. Robert Jarvik and vowed that it is "committing to ensuring greater clarity in the roles and responsibilities of its spokespeople in its consumer advertising and promotion."